Cerebral metabolic responses to 5-HT2A/C receptor activation in mice with genetically modified serotonin transporter (SERT) expression

European Neuropsychopharmacology

Volumn 21, Issue 1, 2011, Pages 117-128

  Dawson, Neil ^a,b   Ferrington, Linda ^a   Lesch, Klaus Peter ^c   Kelly, Paul A T ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

2 Deoxyglucose imaging; 5 HT2A C receptor; Brain function; Serotonin; Serotonin transporter; Transgenic mice

Indexed keywords

SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN TRANSPORTER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN METABOLISM; CONTROLLED STUDY; FEMALE; GENETIC VARIABILITY; GENOTYPE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SEX DIFFERENCE; TRANSGENIC MOUSE;

ANIMALS; BLOOD GLUCOSE; CEREBRUM; FEMALE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; RECEPTOR, SEROTONIN, 5-HT2A; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 78650678064     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2010.10.006     Document Type: Article

References (64)

1. Allen J.P., Allen C.F. Role of the amygdaloid complexes in the stress-induced release of ACTH in the rat. Neuroendocrinology 1974, 15:220-230.
2. Barnes N.M., Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 1999, 38:1083-1152.
3. Bengel D., Greenberg B.D., Cora-Locatelli G., Altemus M., Heils A., Li Q., Murphy D.L. Association of the serotonin transporter promoter regulatory region polymorphism and obsessive-compulsive disorder. Mol. Psychiatry 1999, 4:463-466.
4. Bennett A.J., Lesch K.P., Heils A., Long J.C., Lorenz J.G., Shoaf S.E., Champoux M., Suomi S.J., Linnoila M.V., Higley J.D. Early experience and serotonin transporter gene variation interact to influence primate CNS function. Mol. Psychiatry 2002, 7:118-122.
5. 2C receptors for the treatment of depression. Prog. Brain Res. 2008, 172:287-305.
6. 2C receptors inhibit 5-HT neuronal activity via a GABAergic mechanism. Br. J. Pharmacol. 2006, 149:861-869.
7. Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., McClay J., Mill J., Martin J., Braithwaite A., Poulton R. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003, 301:386-389.
8. Dawson N., Ferrington L., Olverman H.J., Harmar A.J., Kelly P.A.T. Sex influences the effect of a lifelong increase in serotonin transporter function on cerebral metabolism. J. Neurosci. Res. 2009, 87:2375-2385.
9. Ebner K., Bosch O.J., Kromer S.A., Singewald N., Neumann I.D. Release of oxytocin in the rat central amygdala modulates stress-coping behavior and the release of excitatory amino acids. Neuropsychopharmacology 2005, 30:223-230.
10. Feldman S., Newman M.E., Gur E., Weidenfeld J. Role of serotonin in the amygdala in hypothalamo-pituitaryadrenocortical responses. Neuroreport 1998, 9:2007-2009.
11. Fox M.A., Andrews A.M., Wendland J.R., Lesch K.P., Holmes A., Murphy D.L. A pharmacological analysis of mice with a targeted disruption of the serotonin transporter. Psychopharmacology 2007, 195:147-166.
12. Franklin K.B.J., Paxinos G. The Mouse Brain in Stereotaxic Co-ordinates 1997, Academic Press, New York.
13. Freo U., Soncrant T.T., Holloway H.W., Rapoport S.I. Dose-dependent and time-dependent effects of 1-(2, 5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI), a serotonergic 5-HT2 receptor agonist, on local cerebral glucose metabolism in awake rats. Brain Res. 1991, 541:63-69.
14. Freo U., Holloway H.W., Kalogeras K., Rapoport S.I., Soncrant T.T. Adrenalectomy or metyrapone-pretreatment abolishes cerebral metabolic responses to the serotonin agonist 1-(2, 5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) in the hippocampus. Brain Res. 1992, 586:256-264.
15. Furlong R.A., Ho L., Walsh C., Rubinsztein J.S., Jain S., Paykel E.S., Easton D.F., Rubinsztein D.C. Analysis and meta-analysis of two serotonin transporter gene polymorphisms in bipolar and unipolar affective disorders. Am. J. Med. Genet. 1998, 81:58-63.
16. 1A and benzodiazepine receptors in the basolateral amygdala modulate anxiety in the social interaction test, but not in the elevated plus-maze. Brain Res. 1996, 732:145-153.
17. Greenberg B.D., Tolliver T.J., Huang S.J., Li Q., Bengel D., Murphy D.L. Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am. J. Med. Genet. 1999, 88:83-87.
18. Greenberg B., Li Q., Lucas F., Hu S., Sirota L., Benjamin J., Lesch K., Hamer D., Murphy D. Association between the serotonin transporter promoter polymorphism and personality traits in a primarily female population sample. Am. J. Med. Genet. 2000, 96:202-216.
19. Gundlah C., Simon L.D., Auerbach S.B. Differences in hypothalamic serotonin between estrous phases and gender: an in vivo microdialysis study. Brain Res. 1998, 785:91-96.
20. Hariri A.R., Holmes A. Genetics of emotional regulation: the role of the serotonin transporter in neural function. Trends Cogn. Sci. 2006, 10:182-191.
21. Hariri A.R., Mattay V.S., Tessitore A., Kolachana B., Fera F., Goldman D., Egan M.F., Weinberger D.R. Serotonin transporter genetic variation and the response of the human amygdala. Science 2002, 297:400-403.
22. Hariri A.R., Drabant E.M., Munoz K.E., Kolachana B.S., Mattay V.S., Egan M.F., Weinberger D.R. A susceptibility gene for affective disorders and the response of the human amygdala. Arch. Gen. Psychiatry 2005, 62:146-152.
23. Hanna G.L., Himle J.A., Curtis G.C., Koram D.Q., Weele J.V.-V., Leventhal B.L., Cook E.H. Serotonin transporter and seasonal variation in families with obsessive compulsive disorder. Neuropsychopharmacol 1998, 18:102-111.
24. Heinz A., Jones D.W., Mazzanti C., Goldman D., Ragan P., Hommer D., Linnoila M., Weinberger D.R. A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity. Biol. Psychiatry 2000, 47:643-649.
25. Heisler L.K., Zhou L., Bajwa P., Hsu J., Tecott L.H. Serotonin 5-HT2C receptors regulate anxiety-like behavior. Genes Brain Behav. 2007, 6:491-496.
26. Holmes A., Murphy D.L., Crawley J.N. Abnormal behavioral phenotypes of serotonin transporter knockout mice: parallels with human anxiety and depression. Biol. Psychiatry 2003, 54:953-959.
27. 2A function. Br. J. Pharmacol. 2003, 138:U88.
28. Jennings K.A., Loder M.K., Sheward W.J., Pei Q., Deacon R.M.J., Benson M.A., Olverman H.J., Hastie N.D., Harmar A.J., Shen S.B., Sharp T. Increased expression of the 5-HT transporter confers a low-anxiety phenotype linked to decreased 5-HT transmission. J. Neurosci. 2006, 26:8955-8964.
29. 2A receptor function. Neuropharmacology 2008, 54:776-783.
30. Jones M.D., Lucki I. Sex differences in the regulation of serotonergic transmission and behavior in 5-HT receptor knockout mice. Neuropsychopharmacology 2005, 30:1039-1047.
31. Kim H., Lim S.W., Kim S., Kim J.W., Chang Y.H., Carroll B.J., Kim D.K. Monoamine transporter gene polymorphisms and antidepressant response in Koreans with late-life depression. JAMA 2006, 296:1609-1618.
32. Kopchia K.L., Altman H.J., Commissaris R.L. Effects of lesions of the central nucleus of the amygdala on anxiety-like behaviors in the rat. Pharmacol. Biochem. Behav. 1992, 43:453-461.
33. Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., Benjamin J., Muller C.R., Hamer D.H., Murphy D.L. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996, 274:1527-1531.
34. 1A) in 5-HT transporter knock-out mice: gender and brain region differences. J. Neurosci. 2000, 20:7888-7895.
35. 2C receptors in serotonin transporter knockout mice. J. Neurochem. 2003, 84:1256-1265.
36. Li Q., Innis R.B., Seneca N., Ichise M., Huang H., Laruelle M., Murphy D.L. Pharmacological and genetic characterisation of two selective serotonin transporter ligands: 2-[2[(dimethylaminomethylphenylthio)]-5-fluoromethylphenylamine (AMF) and 3-amino-4-[2-(dimethylaminomethyl-phenylthio)]benzonitrile (DASB). J. Pharmacol. Exp. Ther. 2004, 308:481-486.
37. Lira A., Zhou M., Castanon N., Ansorge M.S., Gordon J.A., Francis J.H., Bradley-Moore M., Lira J., Underwood M.D., Arango V., Kung H.F., Hofer M.A., Hen R., Gingrich J.A. Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice. Biol. Psychiatry 2003, 54:960-971.
38. Little K.Y., McLaughlin D.P., Zhang L., Livermore C.S., Dalack G.W., McFinton P.R., Del Proposto Z.S., Hill E., Cassin B.J., Watson S.J., Cook E.H. Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels. Am. J. Psychiatry 1998, 155:207-213.
39. Loder M., Shen S., Wren P., Sharp T., Olverman H.J., Harmar A. The production and analysis of transgenic mice expressing the human serotonin transporter. Eur. J. Neurosci. 2000, 12:173-173.
40. Lotrich F.E., Pollock B.G. Meta-analysis of serotonin transporter polymorphisms and affective disorders. Psychiatr. Genet. 2004, 14:121-129.
41. Mann J.J., Huang J.Y., Underwood M.D., Kassir S.A., Oppenheim S., Kelly T.M., Dwork A.J., Arango V. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical finding in major depression and suicide. Arch. Gen. Psychiatry 2000, 57:729-738.
42. McCulloch J., Kelly P.A.T., Ford I. Effect of apomorphine on the relationship between local cerebral glucose utilization and local cerebral blood flow (with an Appendix on its statistical analysis). J. Cereb. Blood Flow Metab. 1982, 2:487-499.
43. Mitsushima D., Yamada K., Takase K., Funabashi T., Kimura F. Sex differences in the basolateral amygdala: the extracellular levels of serotonin and dopamine, and their responses to restraint stress in rats. Eur. J. Neurosci. 2006, 24:3245-3254.
44. Möller C., Wiklund L., Sommer W., Thorsell A., Heilig M. Decreased experimental anxiety and voluntary ethanol consumption in rats following central but not basolateral amygdala lesions. Brain Res. 1997, 760:94-101.
45. Mufano M.R., Freimer N.B., Ng W., Ophoff R., Veijola J., Miettunen J., Jarvelin M.R., Taanila A., Flint J. 5-HTTLPR genotype and anxiety-related personality traits: a meta-analysis and new data. Am. J. Med. Genet. B 2009, 150B:271-281.
46. Munafo M.R., Clark T., Flint J. Does measurement instrument moderate the association between the serotonin transporter gene and anxiety-related personality traits? A meta-analyis. Mol. Psychiatry 2005, 10:415-419.
47. Parsey R.V., Hastings R.S., Oquendo M.A., Hu X.Z., Goldman D., Huang Y.Y., Simpson N., Arcement J., Huang Y.Y., Ogden R.T., Van Heertum R.L., Arango V., Mann J.J. Effect of a triallelic functional polymorphism of the serotonin transporter-linked promoter region on expression of serotonin transporter in the human brain. Am. J. Psychiatry 2006, 163(1):48-51.
48. Pesold C., Treit D. The central and basolateral amygdala differentially mediate the anxiolytic effects of benzodiazepines. Brain Res. 1995, 671:213-221.
49. 2A/2C receptor signaling via phospholipase A(2) and arachidonic acid is attenuated in mice lacking the serotonin reuptake transporter. Psychopharmacology 2005, 180:12-20.
50. 2A receptors in mice lacking the serotonin transporter. Neurosci. Lett. 1999, 262:113-116.
51. Risch N., Herrell R., Lehner T., Liang K.Y., Eaves L., Hoh J., Griem A., Kovacs M., Ott J., Merikangas K.R. Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and the risk of developing depression. J. Am. Med. Assoc. 2009, 301(24):2462-2471.
52. Rubinow D.R., Schmidt P.J., Roca C.A. Estrogen-serotonin interactions: implications for affective regulation. Biol. Psychiatry 1998, 44:839-850.
53. Schinka J.A., Busch R.M., Robichaux-Keene N. A meta-analysis of the association between the serotonin transporter gene polymorphism (5-HTTLPR) and trait anxiety. Mol. Psychiatry 2004, 9:197-202.
54. Sen S., Burmeister M., Ghosh D. Meta-analysis of the association between a serotonin transporter polymorphism (5-HTTLPR) and anxiety-related personality traits. Am. J. Med. Genet. B 2004, 127B:85-89.
55. Shen H.W., Hagino Y., Kobayashi H., Shinohara-Tanaka K., Ikeda K., Yamamoto H., Yamamoto T., Lesch K.P., Murphy D.L., Hall F.S., Uhl G.R., Sora I. Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters. Neuropsychopharmacology 2004, 29:1790-1799.
56. Shepard J.D., Barron K.W., Myers D.A. Corticosterone delivery to the amygdala increases corticotropin-releasing factor mRNA in the central amygdaloid nucleus and anxiety-like behavior. Brain Res. 2000, 861:288-295.
57. 2A receptor signalling. Mol. Pharmacol. 2006, 71:303-313.
58. Shioe K., Ichimya T., Suhara T., Takano A., Sudo Y., Yasuno F., Hirano M., Shinohara M., Kagami A., Okubo Y., Nankai M., Kanba S. No association between genotype of the promoter region of serotonin transporter gene and serotonin transporter binding in human brain measured by PET. Synapse 2003, 48(4):184-188.
59. Sokoloff L., Reivich M., Kennedy C., DesRosiers M., Patlak C., Pettigrew K., Sakurada O., Shinohara M. 2-Deoxyglucose-C-14 method for measurement of local cerebral glucose-utilization-theory, procedure, and normal values in conscious and anesthetized albino-rat. J. Neurochem. 1977, 28:897-916.
60. Tjurmina O.A., Armando I., Saavedra J.M., Goldstein D.S., Murphy D.L. Exaggerated adrenomedullary response to immobilization in mice with targeted disruption of the serotonin transporter gene. Endocrinology 2002, 143:4520-4526.
61. 123I]beta-CIT SPECT in relation to serotonin transporter genotype. Am. J. Psychiatry 2004, 161:525-531.
62. Weisstaub N.V., Zhou M.M., Lira A., Lambe E., Gonzalez-Maeso J., Hornung J.P., Sibille E., Underwood M., Itohara S., Dauer W.T., Ansorge M.S., Morelli E., Mann J.J., Toth M., Aghajanian G., Sealfon S.C., Hen R., Gingrich J.A. Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice. Science 2006, 313:536-540.
63. Willeit M., Stastny J., Pirker W., Praschak-Rieder N., Neumeister A., Asenbaum S., Tauscher J., Fuchs K., Sieghart W., Hornik K., Aschauer H.N., Brucke T., Kasper S. No evidence for in vivo regulation of midbrain serotonin transporter availability by serotonin transporter promoter gene polymorphism. Biol. Psychiatry 2001, 50(1):8-12.
64. Wrase J., Reimold M., Puls I., Kienast T., Heinz A. Serotonergic dysfunction: brain imaging and behavioural correlates. Cogn. Affect. Behav. Neurosci. 2006, 6:53-61.